Strong Core Masked by Treasury Losses and Regulatory Clouds

Q2 delivered headline growth on the revenue and margin lines, but the profit story is fragmented. Operating profit surged 15.4% sequentially and operating margin expanded 370 basis points to 26.4%, signalling excellent operational leverage. Yet net profit fell 4.1% QoQ to ₹71.7 crore — because treasury losses of ₹17 crore (other income collapsed 82% to ₹3.8 crore from ₹20.8 crore Q1) overwhelmed the core win. This is the gap: a quarter of strong execution shadowed by non-recurring losses and the threat of a regulatory reshuffling in insurance that Prudent hasn't yet quantified.

Operating profit is the honest number here. With revenue up 11.8% QoQ and the operating margin expanding 370 basis points, the core business is firing. The commission payout structure (56.2% of revenue, reaffirmed) is stable, and the cost base is responding to leverage. But "other income" — treasury P&L — fell from ₹20.8 crore Q1 to ₹3.8 crore Q2, a ₹17 crore swing. Management disclosed this upfront: treasury volatility, not a business line issue. If normalized for that headwind, adjusted PAT would be ~₹88–89 crore, a +18–19% QoQ move that would align with operating momentum.

Insurance regulatory risk is now explicit. Prior guidance (Q1 FY27 call) did not flag the IDA/IDE proposal. Management now acknowledges insurance is ~12% of profit and faces margin compression if final rules shift distribution from POSP (5% IDE commission) to agent-centric IDA (10%) model. No quantified offset or contingency plan disclosed; management said 'very difficult to speculate' on margin impact and rested on historical precedent of industry adaptation. This is a step-change in risk disclosure.

PMS-MF license timeline crystallized. Management disclosed April 1, 2027 expected launch for PMS-MF (managing mutual funds directly as a portfolio manager). Margin potential 80–90 bps under regulation (up to 1% fee allowed). This is new optionality vs prior guidance, opening a fee-based HNI revenue stream and reducing insurance commission dependency. Regulatory approval not yet confirmed, but timeline is concrete.

Distributor acceleration is a clear execution lever. Prior guidance mentioned '~30 branch additions FY27,' vague and branch-focused. Management now highlights 3,541 new distributor adds in H1 FY27 (+30% vs H1 FY26), benefiting from MF regulatory tailwind (April 2026 SEBI changes). SIF certifications (1,792 distributors, ₹900 Cr AUM) show scaling and compliance architecture. Pace is ahead of prior branch-centric framing.

The stock is deeply repriced and losing foreign ownership. Prudent trades at ₹2,894.7, down 29.49% from its all-time high of ₹4,105.5. Technically neutral (RSI 41.4), but the stock sits below both its 20-day (₹3,024.71) and 50-day averages, suggesting a longer-term downtrend has reversed. Volume is increasing, indicating institutional interest despite weakness. This is a drawdown-to-valuation story, not a technical collapse.

FII are exiting; DII are edging in. FII ownership fell 60 basis points QoQ to 14.29% (from 14.89% Q1), the fifth consecutive quarter of FII trimming (FII peaked at 17.63% in FY2026 Q4). DII ownership is stable (~23.95%), suggesting domestic institutions are not deeply concerned. The FII exit aligns with broader EM volatility and likely reflects concerns about near-term macro and regulatory clarity in India, not a company-specific repricing.

CEO selling near the highs is a caution signal. Shirish Govindbhai Patel (CEO) sold 2,30,000 shares @ ₹3,325.27, a price ₹430+ above current. This was a sale into strength, pre-regulatory uncertainty and market weakness — not a forced liquidation. Insiders are not voting confidence in near-term support, even as they frame long-term strategy as intact. Flag this as a tactical exit ahead of known risks (insurance regulation, macro weakness).